Showing 161 - 180 results of 428 for search '(( greater decrease ) OR ((( peer decrease ) OR ((( stay decrease ) OR ( diabetes increase ))))))', query time: 0.12s Refine Results
  1. 161

    Deletion of <i>RFX6</i> impairs iPSC-derived islet organoid development and survival, with no impact on PDX1<sup>+</sup>/NKX6.1<sup>+</sup> progenitors by Noura Aldous (15429873)

    Published 2024
    “…Recent studies have also shown <i>RFX6</i> variants to be linked with type 2 diabetes. Despite RFX6’s known function in islet development, its specific role in diabetes pathogenesis remains unclear. …”
  2. 162
  3. 163

    Challenges in child and adolescent health across the Arab Gulf countries—Focus on metabolic health by Basma Haris (12040355)

    Published 2025
    “…The combination of an increasing youth population combined with rapid modernisation, increasing per capita income and the paradigm shift towards unhealthy and affluent lifestyles has created a significant burden of non‐communicable diseases (NCDs), especially obesity and diabetes. …”
  4. 164

    Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors by Najlaa A. Al Thani (17788493)

    Published 2023
    “…<p dir="ltr">Sodium-glucose co-transporter 2 (SGLT2) inhibitors represent one type of new-generation type 2 diabetes (T2DM) drug treatment. The mechanism of action of an SGLT2 inhibitor (SGLT2i) in treating T2DM depends on lowering blood glucose levels effectively via increasing the glomerular excretion of glucose. …”
  5. 165

    Successful use of MiniMed 780G during pregnancy by Khaled Ahmed Baagar (17032266)

    Published 2023
    “…<h3>Background</h3><p dir="ltr">Pregnancy in the setting of type 1 diabetes (T1D) is associated with increased morbidity and mortality. …”
  6. 166

    DNAJB3/HSP-40 cochaperone improves insulin signaling and enhances glucose uptake in vitro through JNK repression by Mohamed Abu-Farha (25322)

    Published 2015
    “…Nevertheless, DNAJB3 expression pattern in diabetic subjects and its mode of action are not yet known. …”
  7. 167

    A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country by Nancy Zaghloul (14147865)

    Published 2022
    “…The trend among SGLT2is suggests greater preference for empagliflozin over dapagliflozin.…”
  8. 168

    Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors by Naila Rabbani (291722)

    Published 2022
    “…<div><p>The abnormal accumulation of methylglyoxal (MG) leading to increased glycation of protein and DNA has emerged as an important metabolic stress, dicarbonyl stress, linked to aging, and disease. …”
  9. 169

    Alpha lipoic acid attenuates ER stress and improves glucose uptake through DNAJB3 cochaperone by Abdoulaye Diane (14152749)

    Published 2020
    “…A similar increase in DNAJB3 mRNA was also observed in HepG2 cells. …”
  10. 170

    Association of Differing Qatari Genotypes with Vitamin D Metabolites by Youssra Dakroury (9991407)

    Published 2020
    “…This may be of specific importance in vitamin D replacement strategies with the Q2 genotype requiring less, and the other genotypes requiring more to increase 1,25(OH)2D. Whilst overall the group was vitamin D deficient, total 25(OH)D was higher in diabetes, but 1,25(OH)2D, 24,25(OH)2D, and 3epi-25(OH)D were lower in diabetes that did not affect the relationship to genotype.…”
  11. 171

    Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal by Zehra Irshad (18614869)

    Published 2019
    “…<p dir="ltr">Metabolic dysfunction of endothelial cells in hyperglycemia contributes to the development of vascular complications of diabetes where increased reactive glycating agent, methylglyoxal (MG), is involved. …”
  12. 172

    Driving and hypoglycemia by Stephen Beer (5480411)

    Published 2015
    “…Unfortunately most diabetes medication can cause hypoglycemia. Hypoglycemia has been associated with cardiac arrhythmia, a decreased ability to drive and driving mishap. …”
  13. 173

    The promise of tirzepatide: A narrative review of metabolic benefits by Sara Sokary (17337724)

    Published 2025
    “…<p>Obesity and type 2 diabetes mellites (T2DM) are intertwined epidemics that continue to pose significant challenges to global public health. …”
  14. 174

    PDX1<sup>−</sup>/NKX6.1<sup>+</sup> progenitors derived from human pluripotent stem cells as a novel source of insulin‐secreting cells by Bushra Memon (4792767)

    Published 2020
    “…<h3>Aim</h3><p dir="ltr">Beta cell replacement strategies are a promising alternative for diabetes treatment. Human pluripotent stem cells (hPSCs) serve as a scalable source for producing insulin-secreting cells for transplantation therapy. …”
  15. 175
  16. 176

    Sense and Learn: Recent Advances in Wearable Sensing and Machine Learning for Blood Glucose Monitoring and Trend-Detection by Ahmad Yaser Alhaddad (7017434)

    Published 2022
    “…There is an increasing demand for non-invasive blood glucose monitoring and trends detection amongst people with diabetes and healthy individuals, especially athletes. …”
  17. 177

    Genetic Deletion of DNAJB3 Using CRISPR-Cas9, Produced Discordant Phenotypes by Shadi Nejat (19457212)

    Published 2023
    “…<p dir="ltr">Several pathways and/or genes have been shown to be dysregulated in obesity-induced insulin resistance (IR) and type 2 diabetes (T2D). We previously showed, for the first time, impaired expression of DNAJB3 mRNA and protein in subjects with obesity, which was concomitant with increased metabolic stress. …”
  18. 178

    DNAJB3 attenuates ER stress through direct interaction with AKT by Zeyaul Islam (5867387)

    Published 2023
    “…<p dir="ltr">Metabolic stress involved in several dysregulation disorders such as type 2 diabetes mellitus (T2DM) results in down regulation of several heat shock proteins (HSPs) including DNAJB3. …”
  19. 179

    Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar by Dalal Al‐Sharshani (19479814)

    Published 2023
    “…<h3>Background</h3><p dir="ltr">Dyslipidemia is recognized as one of the risk factors of cardiovascular diseases (CVDs), type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD).…”
  20. 180

    "Development of Authentic Annual and Seasonal Lightning Thunderstorms Day Maps for Saudi Arabia" by Shwehdi, M. H.

    Published 2006
    “…The southern region in general, and especially the cities of Abha, Taif and Al-Baha, has shown greater numbers of thunderstorm days all year round. …”
    Get full text
    article